QuantLogix ← CHRW scorecard
📅 CHRW Earnings Preview
CHRW
Next report (est.)
10/30/2026
Countdown
3 days
EPS growth YoY
+23.8%
Revenue growth YoY
+19.3%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
07/31/2026 ±10.8% +0.6% over-priced
05/01/2026 ±3.1% -2.5% over-priced
02/13/2026 ±8.0% +4.9% over-priced
10/31/2025 ±5.3% -0.6% over-priced
08/01/2025 ±4.9% -1.3% over-priced
05/02/2025 ±3.2% +0.6% over-priced
02/14/2025 ±2.0% +0.9% over-priced
11/01/2024 ±3.3% -1.2% over-priced
Across these reports, options implied an average ±5.1% move vs an actual average of 1.6% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $1.56 $4.9B $187M
Q1 FY2026 $1.22 $4.0B $147M
Q4 FY2025 — $3.9B $136M
Q3 FY2025 $1.34 $4.1B $163M
Analyst posture
Buy / Strong Buy
24
Hold
7
Sell
1
Strong upward revisions — 32 net (vs 30 prior)
Live 5-factor engine read: Underweight · 38/100 Full scorecard →
Get alerted before every CHRW report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CHRW before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

CHRW (CHRW) reports in 3 days, with the next report estimated for 10/30/2026. Across the last 8 reports, options priced an average ±5.1% earnings move while the stock actually moved 1.6% on average — the market has systematically over-priced CHRW's earnings risk. Fundamentals into the print: EPS up 23.8% year-over-year, revenue up 19.3%. QuantLogix's live 5-factor engine currently reads CHRW as a underweight at 38/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →